Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells".
Level V
Where this comes from
- Record sourced from PubMed, PMID 23740898.
- Also identified by DOI 10.1126/scitranslmed.3005697.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Our work and the study of Bilican et al. highlight the need for complementary assays to detect subtle phenotypic differences between control and mutant induced pluripotent stem cell lines.
Medical subject headings
- Amyotrophic Lateral Sclerosis
- Drug Evaluation, Preclinical
- Induced Pluripotent Stem Cells
- Motor Neurons